These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 392678)

  • 1. [Serologic evaluation of the efficiency of meningococcal capsular polysaccharide vaccines of serogroups A and C: correlation with age, dosage, previous immune status and serological assays].
    Veronesi R; Fayet MT; Stellmann C; Takeda AK; Feldman C; Focaccia R; Mazza CC; Oliveira CE; Sebe E; Adelino M; Diniz JM; Zuccas WA
    Rev Hosp Clin Fac Med Sao Paulo; 1977; 32(5):296-305. PubMed ID: 392678
    [No Abstract]   [Full Text] [Related]  

  • 2. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
    Gold R; Lepow ML
    Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.
    Frøholm LO
    NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045
    [No Abstract]   [Full Text] [Related]  

  • 4. Serologic correlates of protection for evaluating the response to meningococcal vaccines.
    Balmer P; Borrow R
    Expert Rev Vaccines; 2004 Feb; 3(1):77-87. PubMed ID: 14761245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum opsonins to serogroup B meningococci after disease and vaccination.
    Halstensen A; Lehmann AK; Guttormsen HK; Vollset SE; Bjune G; Naess A
    NIPH Ann; 1991 Dec; 14(2):157-65; discussion 166-7. PubMed ID: 1812430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease and its control with meningococcal polysaccharide vaccines.
    Galazka A
    Bull World Health Organ; 1982; 60(1):1-7. PubMed ID: 6979414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal polysaccharide vaccines: recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1977 Sep; 16(9):764-5. PubMed ID: 408072
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children.
    Amato Neto V; Finger H; Gotschlich EC; Feldman RA; de Avila CA; Konichi SR; Laus WC
    Rev Inst Med Trop Sao Paulo; 1974; 16(3):149-53. PubMed ID: 4421873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-meningococcal polysaccharide vaccines].
    Gómez JA; Ferreirós CM; Criado MT
    Enferm Infecc Microbiol Clin; 1997; 15(7):347-8. PubMed ID: 9410045
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunological responses observed in field studies in Africa with group A meningococcal vaccines.
    Gotschlich EC; Rey M; Etienne J; Sanborn WR; Triau R; Cvjetanović B
    Prog Immunobiol Stand; 1971; 5():485-91. PubMed ID: 4633975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Status and development trends in bacterial vaccines illustrated by selected examples].
    Linde K; Dittmann S; Blatz R; Klimm W
    Z Arztl Fortbild (Jena); 1981 Aug; 75(15):669-74. PubMed ID: 7345751
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal disease in São Paulo, Brazil.
    Costa W; Sacchi CT; Ramos S; Milagres L; Prigenzi LS
    NIPH Ann; 1991 Dec; 14(2):215-6; discussion 216-8, 222-4. PubMed ID: 1812434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunoprophylaxis of meningococcal infection among the troops].
    Khokhlov DT; Efimov EI
    Voen Med Zh; 1984 Oct; (10):51-3. PubMed ID: 6438904
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
    Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW
    Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.
    Drogari-Apiranthitou M; Fijen CA; Van De Beek D; Hensen EF; Dankert J; Kuijper EJ
    Clin Exp Immunol; 2000 Feb; 119(2):311-6. PubMed ID: 10632668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.